Clinical trial
Phase 1 Pharmacokinetics of Intravenous Nexium in Children
NCT00474019 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00474019 |
|---|---|
| Title | Phase 1 Pharmacokinetics of Intravenous Nexium in Children |
| Official title | A Phase I, Randomised, Open-label, Multi-National Study to Evaluate the Pharmacokinetics of Repeated Once-Daily Intravenous Doses of Esomeprazole in Paediatric Patients 0 to 17 Years Old, Inclusive. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pharmacokinetics |
| Intervention type | Drug |
| Interventions | esomeprazole |
| Enrollment | 42 |
| Start date | Oct 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | May 16, 2007 |
| Last update posted | Dec 3, 2010 |
| Countries | Australia, Belgium, Hungary, Sweden, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: